In the BioHarmony Drug Report Database

"Preview" Icon

Carboplatin

Paraplatin (carboplatin) is a small molecule pharmaceutical. Carboplatin was first approved as Paraplatin on 1989-03-03. It is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, and esophageal neoplasms amongst others in the USA.

 

Trade Name

 

Paraplatin
 

Common Name

 

carboplatin
 

ChEMBL ID

 

CHEMBL1351
 

Indication

 

bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms, germ cell and embryonal neoplasms, lung neoplasms, osteosarcoma, ovarian neoplasms, urinary bladder neoplasms
 

Drug Class

 

Antineoplastics (platinum derivatives)

Image (chem structure or protein)

Carboplatin structure rendering